SPIMACO signs term sheet with China’s Recbio company to supply HPV vaccines

Saudi Pharmaceutical Industries and Medical Appliances Corporation (“SPIMACO”) signed a (non-binding) term sheet with Jiangsu Recbio Technology Co., Ltd. (“Recbio”) on the licensing, supplying, and technology transfer of recombinant human papillomavirus Vaccine (“HPV Vaccine”).

In a statement on Tadawul, the company announced that this alliance plays a pivotal role in SPIMACO’s strategic initiatives, reinforcing its dedication to promoting the localisation of cutting-edge biopharmaceuticals within the Saudi market. Partnering with Recbio is a vital stride in guaranteeing widespread access to crucial vaccines locally and regionally and, consequently, contributing to the broader enhancement of public health.

It further stated that Based on the Term Sheet, and subject to the definitive agreement, which shall be executed within 9 months from signing of the Term Sheet, SPIMACO will receive an exclusive license to:

• import HPV in finished product form, ready-to-fill bulk product from Recbio and conduct filling and packaging in Saudi Arabia;

• commercialize and distribute Recbio’s HPV vaccine in the Kingdom and the wider MENA region including the application for and obtaining the required marketing authorizations; and

• localize the production of HPV in bulk format following the conclusion of the technology transfer.

The company explained that the fundamental developments will be announced at the appropriate time, and the financial impact will be determined accordingly later.

Additional Information

• The HPV vaccine prevents HPV infections that can progress to cancer, such as cervical cancer.

• Cervical cancer ranks as the 8th most frequent cancer among women in Saudi Arabia and the 8th most chronic cancer among women between 15 and 44 years of age

• Backed by the endorsement of the Saudi Ministry of Health, the HPV vaccine is included in the country’s national immunization schedule with two doses required for females at the age of 11 & 12.